Prati
jerome boursier
jerome boursier
Potvrđena adresa e-pošte na univ-angers.fr
Naslov
Citirano
Citirano
Godina
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
J Boursier, O Mueller, M Barret, M Machado, L Fizanne, F Araujo‐Perez, ...
Hepatology 63 (3), 764-775, 2016
9542016
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
9302016
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
9302016
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
6842019
Determination of reliability criteria for liver stiffness evaluation by transient elastography
J Boursier, JP Zarski, V de Ledinghen, MC Rousselet, N Sturm, B Lebail, ...
Hepatology 57 (3), 1182-1191, 2013
5182013
Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
C Cassinotto, J Boursier, V de Lédinghen, J Lebigot, B Lapuyade, ...
Hepatology 63 (6), 1817-1827, 2016
4602016
A placebo-controlled trial of bezafibrate in primary biliary cholangitis
C Corpechot, O Chazouillères, A Rousseau, A Le Gruyer, F Habersetzer, ...
New England Journal of Medicine 378 (23), 2171-2181, 2018
3712018
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
J Boursier, J Vergniol, A Guillet, JB Hiriart, A Lannes, B Le Bail, ...
Journal of hepatology 65 (3), 570-578, 2016
3312016
Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease
MV Machado, GA Michelotti, G Xie, TP de Almeida, J Boursier, B Bohnic, ...
PloS one 10 (5), e0127991, 2015
3202015
Comparison of blood tests for liver fibrosis specific or not to NAFLD
P Calès, F Lainé, J Boursier, Y Deugnier, V Moal, F Oberti, G Hunault, ...
Journal of hepatology 50 (1), 165-173, 2009
3132009
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation …
PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ...
The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020
2812020
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial
P Mathurin, A Louvet, A Duhamel, P Nahon, N Carbonell, J Boursier, ...
Jama 310 (10), 1033-1041, 2013
2412013
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
CPG Panel, A Berzigotti, E Tsochatzis, J Boursier, L Castera, N Cazzagon, ...
Journal of hepatology 75 (3), 659-689, 2021
2302021
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis
J Boursier, G Isselin, I Fouchard-Hubert, F Oberti, N Dib, J Lebigot, ...
European journal of gastroenterology & hepatology 22 (9), 1074-1084, 2010
1812010
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C
J Vergniol, J Boursier, C Coutzac, S Bertrais, J Foucher, C Angel, ...
Hepatology 60 (1), 65-76, 2014
1582014
Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis
A Louvet, J Labreuche, F Artru, J Boursier, DJ Kim, J O’Grady, E Trépo, ...
Gastroenterology 149 (2), 398-406. e8, 2015
1562015
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
P Calès, V De Ledinghen, P Halfon, Y Bacq, V Leroy, J Boursier, ...
Liver International 28 (10), 1352-1362, 2008
1492008
Reproducibility of liver stiffness measurement by ultrasonographic elastometry
J Boursier, A Konaté, G Gorea, S Reaud, E Quemener, F Oberti, ...
Clinical Gastroenterology and Hepatology 6 (11), 1263-1269, 2008
1432008
The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis
J Boursier, J Vergniol, A Sawadogo, T Dakka, S Michalak, Y Gallois, ...
Liver International 29 (10), 1507-1515, 2009
1412009
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive
J Boursier, V de Ledinghen, JP Zarski, I Fouchard‐Hubert, Y Gallois, ...
Hepatology 55 (1), 58-67, 2012
1402012
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20